miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.

Lechman, Eric R

miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells. [electronic resource] - Cancer cell Feb 2016 - 214-28 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1878-3686

10.1016/j.ccell.2015.12.011 doi


Animals
Antineoplastic Agents--pharmacology
Cell Line, Tumor
Gene Knockdown Techniques
Hematopoietic Stem Cells--pathology
Heterografts
Humans
Leukemia, Myeloid, Acute--genetics
Mice
Mice, SCID
MicroRNAs--genetics
Phosphatidylinositol 3-Kinases--metabolism
Prognosis
Proto-Oncogene Proteins c-akt--metabolism
TOR Serine-Threonine Kinases--metabolism